Search research articles
Contact Us
Filters
Showing results (1-10 of 172) with videos related to
Page
of 18
Sort By:
Research Initiative, Treatment Action : RITA
|
July 9, 2003
HIV-1 Env-chemokine receptor interactions in primary human macrophages: entry and beyond
Ronald G Collman
Expert Opinion on Therapeutic Targets
|
April 23, 2004
HIV-1 entry inhibitors: closing the front door
Brian Tomkowicz, Ronald G Collman
Current Opinion in Infectious Diseases
|
April 20, 2004
Co-receptor antagonists as HIV-1 entry inhibitors
Farida Shaheen, Ronald G Collman
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology
|
September 22, 2009
CNS inflammation and macrophage/microglial biology associated with HIV-1 infection
Anjana Yadav, Ronald G Collman
Journal of Leukocyte Biology
|
August 23, 2006
HIV-1 coreceptor preference is distinct from target cell tropism: a dual-parameter nomenclature to define viral phenotypes
Maureen M Goodenow, Ronald G Collman
Clinics in Laboratory Medicine
|
September 25, 2002
HIV-1 entry and entry inhibitors as therapeutic agents
Linda D Starr-Spires, Ronald G Collman
Journal of Virology
|
January 15, 2005
Preferential use of CXCR4 by R5X4 human immunodeficiency virus type 1 isolates for infection of primary lymphocytes
Yanjie Yi, Farida Shaheen, Ronald G Collman
Microbiome
|
October 4, 2022
Alterations in the respiratory tract microbiome in COVID-19: current observations and potential significance
Carter Merenstein, Frederic D Bushman, Ronald G Collman
Journal of Neurovirology
|
March 30, 2016
Statin modulation of monocyte phenotype and function: implications for HIV-1-associated neurocognitive disorders
Anjana Yadav, Michael R Betts, Ronald G Collman
Current HIV/AIDS Reports
|
March 17, 2015
Persistent high mortality in advanced HIV/TB despite appropriate antiretroviral and antitubercular therapy: an emerging challenge
Gregory P Bisson, Nicola Zetola, Ronald G Collman
Page
of 18
Search research articles
Search
Showing results (1-10 of 172) with videos related to
Sort By:
Page
of 18
Research Initiative, Treatment Action : RITA
|
July 9, 2003
HIV-1 Env-chemokine receptor interactions in primary human macrophages: entry and beyond
Ronald G Collman
Expert Opinion on Therapeutic Targets
|
April 23, 2004
HIV-1 entry inhibitors: closing the front door
Brian Tomkowicz, Ronald G Collman
Current Opinion in Infectious Diseases
|
April 20, 2004
Co-receptor antagonists as HIV-1 entry inhibitors
Farida Shaheen, Ronald G Collman
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology
|
September 22, 2009
CNS inflammation and macrophage/microglial biology associated with HIV-1 infection
Anjana Yadav, Ronald G Collman
Journal of Leukocyte Biology
|
August 23, 2006
HIV-1 coreceptor preference is distinct from target cell tropism: a dual-parameter nomenclature to define viral phenotypes
Maureen M Goodenow, Ronald G Collman
Clinics in Laboratory Medicine
|
September 25, 2002
HIV-1 entry and entry inhibitors as therapeutic agents
Linda D Starr-Spires, Ronald G Collman
Journal of Virology
|
January 15, 2005
Preferential use of CXCR4 by R5X4 human immunodeficiency virus type 1 isolates for infection of primary lymphocytes
Yanjie Yi, Farida Shaheen, Ronald G Collman
Microbiome
|
October 4, 2022
Alterations in the respiratory tract microbiome in COVID-19: current observations and potential significance
Carter Merenstein, Frederic D Bushman, Ronald G Collman
Journal of Neurovirology
|
March 30, 2016
Statin modulation of monocyte phenotype and function: implications for HIV-1-associated neurocognitive disorders
Anjana Yadav, Michael R Betts, Ronald G Collman
Current HIV/AIDS Reports
|
March 17, 2015
Persistent high mortality in advanced HIV/TB despite appropriate antiretroviral and antitubercular therapy: an emerging challenge
Gregory P Bisson, Nicola Zetola, Ronald G Collman
Page
of 18